According to the research report titled ‘Corneal Implants Market Size By Tissue Type (Human Donor, Artificial Cornea), By Transplant Type (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty, Penetrating Keratoplasty), By Condition (Fungal Keratitis, Fuchs Dystrophy, Keratoconus), By End-use (Hospitals, Eye Clinics, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Condition Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with MarketStudyReport, corneal implants market is anticipated to surpass a valuation of USD 500 million by 2025.

Inclination towards minimally invasive eye surgery techniques around the world, growing geriatric population, and rising prevalence of diabetes leading to diabetic retinopathy are the major growth determinants for corneal implants market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/1979113/

For the unversed, corneal implants, which were recently developed, reinforces and flattens the cornea, thereby improving the eyesight of keratoconus patients. Artificial corneal implants are used in minimally invasive treatments to minimize risk & complexity of the procedure, which is likely to augment industry expansion over the forecast duration.

However, shortage of human donor material may stifle the market growth in the coming years.

Based on tissue type, the artificial cornea segment is anticipated to witness 10% CAGR through the forecast timeframe, due to the scarcity of human donor tissue. Also, these implants are ideal substitutes for patients who are intolerant to human donor cornea.

In terms of transplant type, the penetrating keratoplasty segment is held 47% share in worldwide corneal implants industry in 2018 and is expected to grow significantly over the study period, owing to shorter procedure period, less recovery time, and usage of plastic shield during the procedure to protect eye.

On the basis of condition, keratoconus segment is poised to record 6% CAGR during review period, because of necessity for corneal transplant procedures as a result of vision distortion.

Speaking of end-use scope, the eye clinics segment was worth USD 49 million in 2018 and is reckoned to observe notable expansion throughout the forecast period, on account of presence of expert practitioners to diagnose eye diseases.

Regionally, North America industry held 60% revenue share in 2018 and is touted to grow significantly over the estimated timeframe, due to demographic factors, as well as a favorable regulatory environment for corneal implant surgeries, and large proportion of older population suffering from eye problems in the region.

Meanwhile, Asia-Pacific market is predicted to increase at an annual rate of 8% during the study period, because of growing diabetic population, which is affecting eyesight in countries like China, Japan, and India, as well as growing cognizance about the availability of high-quality artificial corneal transplants in the region.

The key players in worldwide corneal implants market are Massachusetts Eye and Ear, KeraMed, Inc., AJL Ophthalmic S.A., DIOPTEX, Aurolab, CorNeat Vision Ltd., San Diego Eye Bank, Presbia plc, Florida Lions Eye Bank, Alcon, Inc., and Alabama Eye Bank.